Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.

Buonagurio DA, Bechert TM, Yang CF, Shutyak L, D'Arco GA, Kazachkov Y, Wang HP, Rojas EA, O'Neill RE, Spaete RR, Coelingh KL, Zamb TJ, Sidhu MS, Udem SA.

Vaccine. 2006 Mar 15;24(12):2151-60. Epub 2005 Nov 21.

PMID:
16413951
2.
3.

Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.

Parks CL, Latham T, Cahill A, O'neill RE, Passarotti CJ, Buonagurio DA, Bechert TM, D'Arco GA, Neumann G, Destefano J, Arendt HE, Obregon J, Shutyak L, Hamm S, Sidhu MS, Zamb TJ, Udem SA.

Virology. 2007 Oct 25;367(2):275-87. Epub 2007 Jun 28. Erratum in: Virology. 2008 May 10;374(2):535-9.

4.
5.

Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting.

Buonagurio DA, O'Neill RE, Shutyak L, D'Arco GA, Bechert TM, Kazachkov Y, Wang HP, DeStefano J, Coelingh KL, August M, Parks CL, Zamb TJ, Sidhu MS, Udem SA.

Virology. 2006 Apr 10;347(2):296-306. Epub 2006 Jan 18.

6.

Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.

Fleming DM, Crovari P, Wahn U, Klemola T, Schlesinger Y, Langussis A, Øymar K, Garcia ML, Krygier A, Costa H, Heininger U, Pregaldien JL, Cheng SM, Skinner J, Razmpour A, Saville M, Gruber WC, Forrest B; CAIV-T Asthma Study Group.

Pediatr Infect Dis J. 2006 Oct;25(10):860-9.

PMID:
17006278
7.

Live cold-adapted influenza A vaccine produced in Vero cell line.

Romanova J, Katinger D, Ferko B, Vcelar B, Sereinig S, Kuznetsov O, Stukova M, Erofeeva M, Kiselev O, Katinger H, Egorov A.

Virus Res. 2004 Jul;103(1-2):187-93.

PMID:
15163508
8.

Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66.

Hoffmann E, Mahmood K, Chen Z, Yang CF, Spaete J, Greenberg HB, Herlocher ML, Jin H, Kemble G.

J Virol. 2005 Sep;79(17):11014-21.

9.
10.

Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial.

Cha TA, Kao K, Zhao J, Fast PE, Mendelman PM, Arvin A.

J Clin Microbiol. 2000 Feb;38(2):839-45.

11.

Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.

Lee KH, Seo SU, Song JM, Lee CM, Kim HA, Seong BL.

Vaccine. 2006 Mar 10;24(11):1966-74. Epub 2005 Nov 8.

PMID:
16343703
13.

Molecular studies of temperature-sensitive replication of the cold-adapted B/Ann Arbor/1/66, the master donor virus for live attenuated influenza FluMist vaccines.

Chen Z, Aspelund A, Kemble G, Jin H.

Virology. 2008 Oct 25;380(2):354-62. doi: 10.1016/j.virol.2008.08.010. Epub 2008 Sep 20.

14.

PB2 and PA genes control the expression of the temperature-sensitive phenotype of cold-adapted B/USSR/60/69 influenza master donor virus.

Kiseleva IV, Voeten JT, Teley LC, Larionova NV, Drieszen-van der Cruijsen SK, Basten SM, Heldens JG, van den Bosch H, Rudenko LG.

J Gen Virol. 2010 Apr;91(Pt 4):931-7. doi: 10.1099/vir.0.017996-0. Epub 2009 Dec 9.

PMID:
20007357
15.

Genetic bases of the temperature-sensitive phenotype of a master donor virus used in live attenuated influenza vaccines: A/Leningrad/134/17/57 (H2N2).

Isakova-Sivak I, Chen LM, Matsuoka Y, Voeten JT, Kiseleva I, Heldens JG, den Bosch Hv, Klimov A, Rudenko L, Cox NJ, Donis RO.

Virology. 2011 Apr 10;412(2):297-305. doi: 10.1016/j.virol.2011.01.004. Epub 2011 Feb 18.

16.

Protective efficacy of intranasal cold-adapted influenza A/New Caledonia/20/99 (H1N1) vaccines comprised of egg- or cell culture-derived reassortants.

Palker T, Kiseleva I, Johnston K, Su Q, Toner T, Szymkowiak C, Kwan WS, Rubin B, Petrukhin L, Wlochowski J, Monteiro J, Kraiouchkine N, DiStefano D, Rudenko L, Shaw A, Youil R.

Virus Res. 2004 Oct;105(2):183-94.

PMID:
15351492
17.

Phenotypic and genetic analyses of the heterogeneous population present in the cold-adapted master donor strain: A/Leningrad/134/17/57 (H2N2).

Youil R, Kiseleva I, Kwan WS, Szymkowiak C, Toner TJ, Su Q, Klimov A, Rudenko L, Shaw AR.

Virus Res. 2004 Jun 15;102(2):165-76.

PMID:
15084398
18.

Safety of the trivalent, cold-adapted influenza vaccine (CAIV-T) in children.

Piedra PA.

Semin Pediatr Infect Dis. 2002 Apr;13(2):90-6. Review.

PMID:
12122958
19.

The development of live attenuated cold-adapted influenza virus vaccine for humans.

Maassab HF, Bryant ML.

Rev Med Virol. 1999 Oct-Dec;9(4):237-44. Review.

20.

[Role of individual genes in expression of phenotypic properties of the cold-adapted strain A/Leningrad/134/47/57 (H2N2)-a donor of attenuation of live influenza vaccine].

Medvedeva TE, Kudriavtseva VK, Nevedomskaia GN, Zhikhareva IV, Gushchina MI, Zolotarev FN, Vodeĭko GM, Lisovskaia KV, Iotov VV, Khaĭder MI.

Genetika. 1993 Apr;29(4):681-9. Russian.

PMID:
8354475

Supplemental Content

Support Center